Yesterday, a single tweet sent the e-commerce community into a flurry of conversation. Maulik Majmudar, all-star cardiologist and associate director of the Healthcare Transformation Lab at Massachusetts General Hospital, announced his departure from academia as he moves to “an exciting & challenging role” at Amazon. While details are sparse, the announcement signals Amazon’s continued investment in healthcare.
Amazon, Berkshire Hathaway, and JPMorgan Chase have been quietly working on a joint healthcare venture, which was considered speculation up until late January when a press release confirmed the partnership. In June, Amazon, Berkshire Hathaway, and JPMorgan Chase released a few major details about their newly-formed company.
Shortly after, Amazon announced plans to acquire PillPack, an online pharmacy. PillPack was introduced in 2013, giving customers who take daily medication a convenient, safe way to consume prescription drugs, over-the-counter medicine, and vitamins. “PillPack’s visionary team has a combination of deep pharmacy experience and a focus on technology,” according to Jeff Wilke, CEO, Amazon Worldwide Consumer. “PillPack is meaningfully improving its customers’ lives, and we want to help them continue making it easy for people to save time, simplify their lives, and feel healthier. We’re excited to see what we can do together on behalf of customers over time.”
The details of Amazon’s plans with their healthcare venture are yet to be seen. Jamie Dimon, CEO of JPMorgan Chase, stated to CNBC that his partnership with Amazon CEO Jeff Bezos to offer healthcare to employees will probably start small and ramp up over time. “I’ll remind people that Jeff Bezos, when he started Amazon, he might have had visions about the ‘everything store,’ but he started with books. And he spent 10 years getting books right.”